Back to search
Prurigo Nodularis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The main aim of this study is to assess real-world effectiveness of nemolizumab in Prurigo nodularis (PN) as measured by investigator and patient reported outco…
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with Prurigo Nodularis.
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
This is a Phase 3, multicenter, open-label, pharmacokinetics (PK)/safety study. The study consists of 3 periods: * Screening period: 2 to 4 weeks. * Treatment…
With the arrival of dupilumab as the first available targeted therapy for PN, there is an unmet need for real-world data and translational research on the worki…
Prurigo nodularis (PN) is a skin disease characterized by the presence of single to multiple symmetrically distributed, intensively itching nodules. The main sy…
This study is the first-in-human (FIH) study of BGB-45035. The study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGB-45035…
The purpose of this study is to evaluate the effectiveness of lebrikizumab in treating adults with moderate-to-severe Prurigo Nodularis (PN).